WELL Health Technologies (TSE:WELL) Sets New 1-Year High on Analyst Upgrade

WELL Health Technologies Corp. (TSE:WELL)’s share price reached a new 52-week high on Tuesday after Royal Bank of Canada raised their price target on the stock from C$7.00 to C$8.50. The company traded as high as C$7.30 and last traded at C$7.23, with a volume of 1354392 shares traded. The stock had previously closed at C$6.95.

A number of other analysts have also recently commented on WELL. Ventum Financial lowered their target price on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th. TD Securities upped their target price on WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday, December 17th. Haywood Securities lifted their price target on WELL Health Technologies from C$8.00 to C$10.00 in a research report on Friday, December 13th. CIBC boosted their price target on WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday, December 13th. Finally, Raymond James raised their price objective on WELL Health Technologies from C$10.00 to C$11.00 in a research note on Tuesday, December 17th.

WELL Health Technologies Stock Performance

The firm’s 50 day moving average is C$5.94 and its 200-day moving average is C$5.03. The stock has a market capitalization of C$1.81 billion, a price-to-earnings ratio of 12.74, a PEG ratio of -1.93 and a beta of 1.20. The company has a debt-to-equity ratio of 41.57, a quick ratio of 1.02 and a current ratio of 1.25.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.